Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register
about
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing.Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden.Role of targeted therapy in combination with surgery in renal cell carcinoma.Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.Is there a difference in clinicopathological outcomes of renal tumor between young and old patients? A multicenter matched-pair analysis.Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in rena[Should cytoreductive nephrectomy be performed in patients with metastatic renal cell carcinoma and what is the scientific rationale?]Alcohol consumption and the risk of renal cancers in the European prospective investigation into cancer and nutrition (EPIC).Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review
P2860
Q35750117-530CFB1D-144A-482A-9B4C-2AB2B6E494CBQ36163444-FC4F2595-BA10-48B4-95F1-887F482815C4Q36204192-907A6079-7F18-4236-8D3F-FA8B7863BF38Q38560110-F9C14CD6-047A-4EF8-A402-AD8C055CAC02Q38681585-10B23128-8BDD-4A41-87B4-BCC484F27D0AQ40022143-684B1562-9639-4D01-97DC-FF23D5AD5531Q40651708-54C99469-32AB-425C-8B2C-C931750825E9Q40705829-227A0DAA-50E3-4BFA-82BE-0F3C3E54BA90Q40707127-DDBCBDA2-DF77-42F0-87D8-C596494E19B0Q40909577-D497A0AD-3D76-4F4D-B26F-CAD5DAC0FA7CQ40937833-E81344BE-68B6-478E-B9FE-18D6D1A3B2C3Q41065096-D6C92A2F-5DF5-4AB0-B722-E815C887F078Q50791794-B36D8BA1-71EA-4707-BAC1-B0799405CF20Q50936317-A476822D-CD8D-4D4A-95E5-C331BA5E0FDBQ58585062-E844B5EB-B049-4DAB-A8F0-377CDE53499D
P2860
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register
description
scientific article published on 25 March 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2014
@uk
name
Tumour characteristics and sur ...... Swedish Kidney Cancer Register
@en
Tumour characteristics and sur ...... Swedish Kidney Cancer Register
@nl
type
label
Tumour characteristics and sur ...... Swedish Kidney Cancer Register
@en
Tumour characteristics and sur ...... Swedish Kidney Cancer Register
@nl
prefLabel
Tumour characteristics and sur ...... Swedish Kidney Cancer Register
@en
Tumour characteristics and sur ...... Swedish Kidney Cancer Register
@nl
P2093
P2860
P1476
Tumour characteristics and sur ...... Swedish kidney cancer register
@en
P2093
Andreas Thorstenson
Ann-Helén Scherman-Plogell
Martin Bergman
Soheila Hosseinnia
Sven Lundstam
P2860
P304
P356
10.3109/21681805.2013.864698
P577
2014-03-25T00:00:00Z